Glucocorticoid receptor antagonism by mifepristone alters phosphocreatine breakdown during sepsis

Tadashi Mitsuo, Jan Rounds, Derek Prechek, Douglas W. Wilmore, Danny O. Jacobs

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To determine the role of glucocorticoids in the regulation of myocellular energetics induced by sepsis by means of the glucocorticoid receptor antagonist mifepristone (RU 38486). Design: Randomized controlled study. Setting: University laboratories. Participants: Thirty-two adult male Wistar rats. Methods: Animals were randomly assigned to 1 of 4 groups. In 2 groups, mifepristone (10 mg/kg) was administered by gavage feeding 2 hours before cecal ligation and single 18-gauge needle puncture or sham operation. The other 2 groups of animals received placebo gavage feedings 2 hours before their surgical procedures. Twenty-four hours after operation, high-energy phosphate ratios, intracellular pH, the forward rate constant for the creatine kinase reaction, and phosphocreatine breakdown rates were measured in the gastrocnemius muscle by in vivo phosphorus 31 magnetic resonance spectroscopy. Tissue and blood samples were collected to measure creatine and adenosine 5'-triphosphate concentrations, Na+-K+ adenosine triphosphatase activity, and circulating corticosterone levels. Results: Circulating corticosterone levels were twice as high in septic animals as in sham- operation control rats (P<.01). Phosphocreatine breakdown rates and Na+-K+ adenosine triphosphatase activity were significantly higher (40% and 75%, respectively; P<.01) in placebo-treated septic rats than in sham-operation control rats. However, phosphocreatine breakdown rates and Na+-K+ adenosine triphosphatase activity in mifepristone-treated septic animals were not significantly elevated above control levels. Conclusion: Pretreatment with mifepristone reduces the demand for adenosine triphosphate production from phosphocreatine breakdown and downregulates Na+-K+ adenosine triphosphatase activity during sepsis.

Original languageEnglish
Pages (from-to)1179-1185
Number of pages7
JournalArchives of Surgery
Volume131
Issue number11
StatePublished - Nov 1996
Externally publishedYes

Fingerprint

Mifepristone
Phosphocreatine
Glucocorticoid Receptors
Sepsis
Adenosine Triphosphatases
Corticosterone
Adenosine Triphosphate
Placebos
Creatine
Creatine Kinase
Punctures
Phosphorus
Glucocorticoids
Needles
Ligation
Wistar Rats
Skeletal Muscle
Magnetic Resonance Spectroscopy
Down-Regulation
Phosphates

ASJC Scopus subject areas

  • Surgery

Cite this

Mitsuo, T., Rounds, J., Prechek, D., Wilmore, D. W., & Jacobs, D. O. (1996). Glucocorticoid receptor antagonism by mifepristone alters phosphocreatine breakdown during sepsis. Archives of Surgery, 131(11), 1179-1185.

Glucocorticoid receptor antagonism by mifepristone alters phosphocreatine breakdown during sepsis. / Mitsuo, Tadashi; Rounds, Jan; Prechek, Derek; Wilmore, Douglas W.; Jacobs, Danny O.

In: Archives of Surgery, Vol. 131, No. 11, 11.1996, p. 1179-1185.

Research output: Contribution to journalArticle

Mitsuo, T, Rounds, J, Prechek, D, Wilmore, DW & Jacobs, DO 1996, 'Glucocorticoid receptor antagonism by mifepristone alters phosphocreatine breakdown during sepsis', Archives of Surgery, vol. 131, no. 11, pp. 1179-1185.
Mitsuo T, Rounds J, Prechek D, Wilmore DW, Jacobs DO. Glucocorticoid receptor antagonism by mifepristone alters phosphocreatine breakdown during sepsis. Archives of Surgery. 1996 Nov;131(11):1179-1185.
Mitsuo, Tadashi ; Rounds, Jan ; Prechek, Derek ; Wilmore, Douglas W. ; Jacobs, Danny O. / Glucocorticoid receptor antagonism by mifepristone alters phosphocreatine breakdown during sepsis. In: Archives of Surgery. 1996 ; Vol. 131, No. 11. pp. 1179-1185.
@article{b8df49adaea24af68290ee2e373a965a,
title = "Glucocorticoid receptor antagonism by mifepristone alters phosphocreatine breakdown during sepsis",
abstract = "Objective: To determine the role of glucocorticoids in the regulation of myocellular energetics induced by sepsis by means of the glucocorticoid receptor antagonist mifepristone (RU 38486). Design: Randomized controlled study. Setting: University laboratories. Participants: Thirty-two adult male Wistar rats. Methods: Animals were randomly assigned to 1 of 4 groups. In 2 groups, mifepristone (10 mg/kg) was administered by gavage feeding 2 hours before cecal ligation and single 18-gauge needle puncture or sham operation. The other 2 groups of animals received placebo gavage feedings 2 hours before their surgical procedures. Twenty-four hours after operation, high-energy phosphate ratios, intracellular pH, the forward rate constant for the creatine kinase reaction, and phosphocreatine breakdown rates were measured in the gastrocnemius muscle by in vivo phosphorus 31 magnetic resonance spectroscopy. Tissue and blood samples were collected to measure creatine and adenosine 5'-triphosphate concentrations, Na+-K+ adenosine triphosphatase activity, and circulating corticosterone levels. Results: Circulating corticosterone levels were twice as high in septic animals as in sham- operation control rats (P<.01). Phosphocreatine breakdown rates and Na+-K+ adenosine triphosphatase activity were significantly higher (40{\%} and 75{\%}, respectively; P<.01) in placebo-treated septic rats than in sham-operation control rats. However, phosphocreatine breakdown rates and Na+-K+ adenosine triphosphatase activity in mifepristone-treated septic animals were not significantly elevated above control levels. Conclusion: Pretreatment with mifepristone reduces the demand for adenosine triphosphate production from phosphocreatine breakdown and downregulates Na+-K+ adenosine triphosphatase activity during sepsis.",
author = "Tadashi Mitsuo and Jan Rounds and Derek Prechek and Wilmore, {Douglas W.} and Jacobs, {Danny O.}",
year = "1996",
month = "11",
language = "English",
volume = "131",
pages = "1179--1185",
journal = "JAMA Surgery",
issn = "2168-6254",
publisher = "American Medical Association",
number = "11",

}

TY - JOUR

T1 - Glucocorticoid receptor antagonism by mifepristone alters phosphocreatine breakdown during sepsis

AU - Mitsuo, Tadashi

AU - Rounds, Jan

AU - Prechek, Derek

AU - Wilmore, Douglas W.

AU - Jacobs, Danny O.

PY - 1996/11

Y1 - 1996/11

N2 - Objective: To determine the role of glucocorticoids in the regulation of myocellular energetics induced by sepsis by means of the glucocorticoid receptor antagonist mifepristone (RU 38486). Design: Randomized controlled study. Setting: University laboratories. Participants: Thirty-two adult male Wistar rats. Methods: Animals were randomly assigned to 1 of 4 groups. In 2 groups, mifepristone (10 mg/kg) was administered by gavage feeding 2 hours before cecal ligation and single 18-gauge needle puncture or sham operation. The other 2 groups of animals received placebo gavage feedings 2 hours before their surgical procedures. Twenty-four hours after operation, high-energy phosphate ratios, intracellular pH, the forward rate constant for the creatine kinase reaction, and phosphocreatine breakdown rates were measured in the gastrocnemius muscle by in vivo phosphorus 31 magnetic resonance spectroscopy. Tissue and blood samples were collected to measure creatine and adenosine 5'-triphosphate concentrations, Na+-K+ adenosine triphosphatase activity, and circulating corticosterone levels. Results: Circulating corticosterone levels were twice as high in septic animals as in sham- operation control rats (P<.01). Phosphocreatine breakdown rates and Na+-K+ adenosine triphosphatase activity were significantly higher (40% and 75%, respectively; P<.01) in placebo-treated septic rats than in sham-operation control rats. However, phosphocreatine breakdown rates and Na+-K+ adenosine triphosphatase activity in mifepristone-treated septic animals were not significantly elevated above control levels. Conclusion: Pretreatment with mifepristone reduces the demand for adenosine triphosphate production from phosphocreatine breakdown and downregulates Na+-K+ adenosine triphosphatase activity during sepsis.

AB - Objective: To determine the role of glucocorticoids in the regulation of myocellular energetics induced by sepsis by means of the glucocorticoid receptor antagonist mifepristone (RU 38486). Design: Randomized controlled study. Setting: University laboratories. Participants: Thirty-two adult male Wistar rats. Methods: Animals were randomly assigned to 1 of 4 groups. In 2 groups, mifepristone (10 mg/kg) was administered by gavage feeding 2 hours before cecal ligation and single 18-gauge needle puncture or sham operation. The other 2 groups of animals received placebo gavage feedings 2 hours before their surgical procedures. Twenty-four hours after operation, high-energy phosphate ratios, intracellular pH, the forward rate constant for the creatine kinase reaction, and phosphocreatine breakdown rates were measured in the gastrocnemius muscle by in vivo phosphorus 31 magnetic resonance spectroscopy. Tissue and blood samples were collected to measure creatine and adenosine 5'-triphosphate concentrations, Na+-K+ adenosine triphosphatase activity, and circulating corticosterone levels. Results: Circulating corticosterone levels were twice as high in septic animals as in sham- operation control rats (P<.01). Phosphocreatine breakdown rates and Na+-K+ adenosine triphosphatase activity were significantly higher (40% and 75%, respectively; P<.01) in placebo-treated septic rats than in sham-operation control rats. However, phosphocreatine breakdown rates and Na+-K+ adenosine triphosphatase activity in mifepristone-treated septic animals were not significantly elevated above control levels. Conclusion: Pretreatment with mifepristone reduces the demand for adenosine triphosphate production from phosphocreatine breakdown and downregulates Na+-K+ adenosine triphosphatase activity during sepsis.

UR - http://www.scopus.com/inward/record.url?scp=0029855086&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029855086&partnerID=8YFLogxK

M3 - Article

VL - 131

SP - 1179

EP - 1185

JO - JAMA Surgery

JF - JAMA Surgery

SN - 2168-6254

IS - 11

ER -